Novel Drug Launches in Most-Favored-Nation Countries and Medicare Pricing Benchmarks

JAMA Health Forum · Published 2026-07-31 · DOI 10.1001/jamahealthforum.2026.2340

Free full text

Authors (5)

Mengyuan Fu, Rohini Ghosh, Erfan Taherifard, Reshma Ramachandran, Joseph S. Ross

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Fu, M., Ghosh, R., Taherifard, E., et al. (2026). Novel Drug Launches in Most-Favored-Nation Countries and Medicare Pricing Benchmarks. JAMA Health Forum. https://doi.org/10.1001/jamahealthforum.2026.2340

Related articles

• JAMA Health Forum · JAMA Health Forum · 2026 · Same journal
• Error in Table 3 · JAMA Health Forum · 2026 · Same journal
• Medicaid Expansion and Mortality Among Formerly Incarcerated Individuals · JAMA Health Forum · 2026 · Same journal
• Making the FDA Great Again · JAMA Health Forum · 2026 · Same journal
• Losing Our Lens on Maternal and Infant Health—The Consequences of Disrupting PRAMS · JAMA Health Forum · 2026 · Same journal
• Product Reformulation in Response to the 2016 FDA Updated Nutrition Facts Label · JAMA Health Forum · 2026 · Same journal
• Ultralow-Volume Treatments for Mosquito-Borne Diseases · JAMA Health Forum · 2026 · Same journal
• State-Level Abortion Bans and the OBGYN Workforce · JAMA Health Forum · 2026 · Same journal
• Institutional Variation in Life-Sustaining Treatments and Mortality Among Older Patients · JAMA Health Forum · 2026 · Same journal
• Trends and Factors in Nursing Home Closures · JAMA Health Forum · 2026 · Same journal